OTCMKTS:DNAG DNAPrint Genomics (DNAG) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About DNAPrint Genomics Stock (OTCMKTS:DNAG) Get DNAPrint Genomics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume274,000 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview DNAPrint Genomics (OTCMKTS:DNAG) is a molecular diagnostics company specializing in direct-to-consumer and clinical genetic testing services. The company’s core offerings include ancestry determination tests that estimate an individual’s ethnic origins and geographic lineage by analyzing autosomal DNA markers. In addition, DNAPrint Genomics has developed nutrigenomic and pharmacogenomic panels designed to provide insights into how genetic variations may influence dietary responses and drug metabolism. Through its online platform and partnerships with healthcare practitioners, DNAPrint Genomics delivers customized reports that integrate genetic profiles with ancestral and wellness information. The company’s products are marketed under branded services that guide users in interpreting their genetic data and making informed lifestyle or medical decisions. DNAPrint Genomics has also collaborated with research institutions to expand its test catalog and validate new genetic markers for population studies. Founded in the early 2000s and headquartered in Gainesville, Florida, DNAPrint Genomics has pursued a strategy of global distribution, with service availability in North America, Europe and select Asian markets. While detailed leadership information is limited, the company’s management team has historically included professionals with backgrounds in molecular biology, bioinformatics and consumer health. DNAPrint Genomics continues to position itself in the personalized medicine space by leveraging advances in genomic technology and data analytics.AI Generated. May Contain Errors. Read More Receive DNAG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DNAPrint Genomics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DNAG Stock News HeadlinesNucleus Genomics CEO explains how "genetic optimization" tools help parents select traits they desire in babiesDecember 3, 2025 | cbsnews.comComparing DNA language models to guide optimal AI selection for genomicsDecember 2, 2025 | msn.comA huge SpaceX error just led one stock to 3X move!SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker. That window has closed - but the next opportunity may still be open. Trader Lance Ippolito has released a free SpaceX Investing Blackbook covering pre-IPO positioning plays, the space stock Goldman Sachs, BlackRock, and Morgan Stanley are loading up on, and the chip supplier Starlink satellites depend on.June 20 at 1:00 AM | InvestPub (Ad)Uptake of DNA fragments from dying cells could redefine mammalian evolution and genomicsSeptember 26, 2025 | msn.comGenetics testing startup Nucleus Genomics criticized for its embryo product: ‘Makes me so nauseous’June 7, 2025 | msn.comThe Accelerating Pace Of Genomics Technologies For Plants And AnimalsFebruary 5, 2025 | forbes.comAI model learns generalized 'language' of regulatory genomics, predicts cellular storiesJanuary 30, 2025 | msn.comControversial genetics testing startup Nucleus Genomics raises $14M Series AJanuary 30, 2025 | msn.comSee More Headlines DNAG Stock Analysis - Frequently Asked Questions How do I buy shares of DNAPrint Genomics? Shares of DNAG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DNAPrint Genomics own? Based on aggregate information from My MarketBeat watchlists, some other companies that DNAPrint Genomics investors own include Editas Medicine (EDIT), Pacira BioSciences (PCRX), BioStem Technologies (BSEM), Berkshire Hathaway (BRK.B), Bristol Myers Squibb (BMY), Bitwise Crypto Industry Innovators ETF (BITQ) and Black Diamond Therapeutics (BDTX). Company Calendar Today6/20/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryBusiness Services Current SymbolOTCMKTS:DNAG CIKN/A Webwww.dnaprint.com Phone(941) 366-3400Fax941-952-9770Employees24Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:DNAG) was last updated on 6/20/2026 by MarketBeat.com Staff. From Our PartnersForget the million-dollar nest eggNearly 2 in 3 Americans fear running out of money more than death - and chasing a $1.5 million nest egg isn't ...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredPrint this before your next tradeBill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It'...Profits Run | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredElon Is Quietly Doubling Down on This Bizarre AssetYahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DNAPrint Genomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DNAPrint Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
